Alexander Förderer from the Max-Planck Institute of Molecular Plant Physiology receives €2.85 million from the German Federal Ministry of Education and Research to study the harmful and beneficial relationships between plants and the microbes that surround them.
  more

From May 22^nd to 24^th, a delegation of 15 doctoral researchers from the Potsdam-Golm Max Planck Institute of Molecular Plant Physiology (MPIMP) visited the Max Planck Institute for Plant Breeding Research (MPIPZ) in Cologne. This was the first inter-MPI event connecting PhD students from the two plant institutes, initiated by the PhD representatives of both institutes.
  more

Scientists discover key regulators of seed development in a parental stalemate more

Max Planck Institute in Potsdam receives EU funding of 2.5 million euros for groundbreaking research on plant mitochondria.
  more

How biofortification can improve nutrition more

Researchers from the Max Planck Institute of Molecular Plant Physiology unravel the biosynthetic pathway of paclitaxel in Yew plants, a most successfully used chemotherapeutic for cancer treatment. This discovery might facilitate the production of this very complex molecule which is currently produced with great efforts and high costs.
  more

Top researcher from Potsdam receives €2 million for research into an underground relationship between plants and fungi. more

Scientists at the Max Planck Institute of Molecular Plant Physiology in Potsdam Science Park are among the most cited scientists in the world!
  more

Viruses are a threat to all organisms, including plants. A small group of plant stem cells, however, successfully defends itself from infection. Marco Incarbone, now at MPIMP Golm, Gabriele Bradamante and their co-authors at the Gregor Mendel Institute of Molecular Plant Biology (GMI) uncovered that salicylic acid and RNA interference mediate this antiviral immunity of plant stem cells. The findings are published in PNAS on October 12.
  more

The Max Planck Institute of Molecular Plant Physiology welcomes two new independent research group leaders, Dr. Marion Clavel and Dr. Marco Incarbone!
  more